Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 4

Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women

University of Delaware · with National Institute on Aging (NIA) · NCT06745466

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 40–55 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Phase 4
Target enrollment
30
US sites recruiting
1
Study start
November 15, 2024
Record last updated
July 2, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to identify the impact of estradiol (E2) on the associations between (a) responsivity to daily stress or (b) sleep variability with vascular function in midlife premenopausal women.

Being studied: ganirelix acetate

Conditions: Estrogen; Premenopause

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Female
  • Age 40-55
  • Premenopausal

Exclusion Criteria

  • Pregnancy (including a positive urine pregnancy test), planning to become pregnant, or breast-feeding
  • Peri- or post-menopausal
  • Unstable or diagnosed chronic clinical disease, including cardiovascular, metabolic, renal, hepatic, autonomic, autoimmune, or dermatological disease
  • Current or lifetime major psychiatric illness (e.g., major depressive disorder, bipolar disorder, schizophrenia, eating disorders)
  • History of hysterectomy (complete or partial), polycystic ovary syndrome, endometrial hyperplasia, irregular menstrual cycles, or endometrial ablation
  • Suspected potential presence of obstructive sleep apnea (STOP-Bang score >3) or insomnia (Insomnia Severity Index score >15)
  • Current or recent (within 8 wks) use of medications that could conceivably alter cardiovascular function or sleep health
  • Changes or alterations in medication status (starting a new, additional, or different medication or changing the dose of a current medication)
  • Body mass index >35 kg/m2
  • Tobacco or nicotine use, including vaping and electronic cigarettes
  • Working night-time or rotating shift work within the previous 3 months
  • Trans-meridian travel during study enrollment (inclusive of the entire duration of enrollment and the period between testing cycles)
  • Known allergies to pharmacological agents/drugs
  • Current use of long-acting reversible contraception (LARC; e.g., IUDs, birth control implants)
  • Known latex allergy

Recruiting US locations

  • University of Delaware

    Newark, DE 19713

    Site contact: Jody Greaney, PhD · 302-831-2193 · jgreaney@udel.edu

Study contacts (from the official record)

  • Jody Greaney, PhD · 302-831-2193 · jgreaney@udel.edu
  • Virginia Nuckols, PhD · gnuckols@udel.edu
All sleep studies in Delaware →
Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones… (NCT06745466) | Bored Studies